MET and lung adenocarcinoma: For instance, the Hepatocyte growth factor (HGF)/c-mesenchymal-epithelial transition factor (c-Met), HGF/c-Met signaling pathway regulates the cirRNA CCDC66 expression to promote EMT and cisplatin resistance in lung adenocarcinoma cells [71].